A carregar...
Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort
BACKGROUND: To assess efficacy and safety of treatment simplification to co-formulated Rilpivirine/Emtricitabine/Tenofovir (RPV/FTC/TDF) in virologically suppressed patients. MATERIALS AND METHODS: Endpoints of the analysis were: (a) treatment discontinuation of RPV/FTC/TDF for any reasons and (b) o...
Na minha lista:
Publicado no: | J Int AIDS Soc |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
International AIDS Society
2014
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4225448/ https://ncbi.nlm.nih.gov/pubmed/25397556 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7448/IAS.17.4.19812 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|